Nov 14, 2025 08:01AM
Mar 17, 2025 09:09AM
Nov 12, 2024 09:55PM
Nov 12, 2024 04:00PM
Nov 5, 2024 09:00AM
Aug 6, 2024 05:13PM
Aug 6, 2024 04:00PM GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
Jul 30, 2024 09:00AM
May 14, 2024 04:09PM
May 7, 2024 09:09AM
Mar 1, 2024 06:48AM
Feb 29, 2024 04:00PM
Feb 22, 2024 09:00AM
Nov 8, 2023 04:00PM GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update
Oct 31, 2023 09:00AM
Oct 24, 2023 09:01AM
Oct 24, 2023 09:00AM
Aug 9, 2023 05:40PM
Aug 9, 2023 04:00PM
Jul 26, 2023 09:00AM
May 4, 2023 04:00PM GeoVax Reports 2023 First Quarter Financial Results and Provides Corporate Update
Apr 25, 2023 09:00AM
Mar 23, 2023 04:58PM
Mar 23, 2023 04:00PM
Mar 9, 2023 09:00AM
Nov 9, 2022 04:30PM
Nov 9, 2022 04:00PM
Oct 26, 2022 09:00AM GeoVax to Host Third Quarter 2022 Business Update and Financial Results Conference Call on November 9, 2022
Aug 3, 2022 04:00PM
Jul 26, 2022 09:00AM
Apr 27, 2022 04:00PM
Apr 19, 2022 09:00AM
Apr 19, 2022 09:00AM
Mar 9, 2022 04:04PM
Mar 9, 2022 04:00PM GeoVax Reports 2021 Year-End Financial Results and Provides Corporate Update
Mar 9, 2022 04:00PM
Feb 23, 2022 09:00AM
Feb 23, 2022 09:00AM
Dec 14, 2021 09:00AM
Dec 14, 2021 09:00AM
Dec 14, 2021 09:00AM
Nov 11, 2021 04:00PM GeoVax Reports 2021 Third Quarter Financial Results and Provides Corporate Update
Nov 11, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 9, 2021 04:00PM
Nov 4, 2021 09:00AM
Nov 4, 2021 09:00AM
Oct 14, 2021 09:01AM Geovax Labs Inc. (GOVX) Receives Patent for Ebola Vaccine
Oct 14, 2021 09:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All